Super-refractory Status Epilepticus: Clinical Trials

1 trial for Super-refractory Status Epilepticus, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 completed. 1 Phase 1, 1 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 11Completed 1
Phase 21Completed 1

Follow Super-refractory Status Epilepticus: new trials by email Literature Review of Super-refractory Status Epilepticus trials Research Report on Super-refractory Status Epilepticus

Trials (filtered) newest first · largest first

All 1 trial

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Study to Evaluate SAGE-547 Injection as Adjunctive Therapy for the Treatment of Super-Refractory Status Epilepticus
SAGE-547 - Super-refractory Status Epilepticus
Phase 1 / Phase 2CompletedSupernus Pharmaceuticals, Inc.252014-03-212025-09-15

Narrower conditions

Status Epilepticus (1)

Broader conditions

Nervous System Diseases (1)  ·  Neurologic Manifestations (1)  ·  Pathological Conditions, Signs and Symptoms (1)  ·  Seizures (1)  ·  Signs and Symptoms (1)

Interventions

brexanolone (1)

Sponsors

Supernus Pharmaceuticals, Inc. (1)

Countries

United States (1)

Top investigators

Robert Lasser, MD, MBA (1)